Polyplus-transfection Polygenic Risk Scores Can Differ for Same Disease in Individuals, Hampering Clinical Implementation Premium The issue may lie in how the same data is analyzed to construct different PRS, posing a challenge for using and discussing the risk scores in the clinic. BioHelix Gets $300K Phase I SBIR to Enhance Isothermal Method with ZNA Tech for HIV Assay Premium By Ben Butkus Polyplus-transfection Enters Reagent Deal with Roche Glycart The licensing deal grants Roche Glycart access to polyethylenimine for in vitro transfection applications for research purposes. Polyplus Raises $3.3M in Private Financing Premium The company said it will use the funds to advance new siRNA delivery compounds and add 10 new researchers and lab technicians. Polyplus-transfection Raises $3.2M The company plans to use the funding to enhance its R&D resources and to hire new researchers and lab technicians. Mar 4, 2010 France's Polyplus-transfection Licenses Oligonucleotide Tech to Metabion Premium Mar 2, 2010 Polyplus-transfection Licenses ZNA Oligonucleotides to Metabion Jan 21, 2010 Polyplus-transfection Demonstrates Use of ZNAs as Short Hydrolysis Probes for qPCR Premium Dec 10, 2009 Polyplus Raises $1.8M Through Convertible Bond Issuance Premium Dec 9, 2009 Polyplus-transfection Lands $1.8M Financing Nov 3, 2009 Sigma-Aldrich Licenses Polyplus-transfection's ZNA Technology Breaking News Genetic Contributors to Plasma Protein Levels Unearthed in Multiple Studies Standard BioTools, SomaLogic to Merge Arima Genomics, Protean BioDiagnostics Launch 3D Genomics Cancer Testing Joint Venture Pathnostics UTI Test Nabs New York State Approval NanoString, A*Star, Next Level Genomics to Launch Spatial Biology Laboratory in Singapore The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.